Staged Mucosal Advancement Flap versus Staged Fibrin Sealant in the Treatment of Complex Perianal Fistulas
2011

Comparing Two Treatments for Complex Perianal Fistulas

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): S. J. van der Hagen, C. G. Baeten, P. B. Soeters, W. G. van Gemert

Primary Institution: Academic Hospital of Maastricht

Hypothesis

Is the staged mucosal advancement flap more effective than staged fibrin sealant in treating complex perianal fistulas?

Conclusion

Staged fibrin sealant injection has a much lower success rate compared to mucosal advancement flap.

Supporting Evidence

  • 20% of patients in the MF group had a recurrent fistula compared to 60% in the FS group.
  • No new continence disorders developed in either treatment group.
  • The study included 30 patients treated between 2005 and 2006.

Takeaway

Doctors tested two ways to fix a problem with the bottom called perianal fistulas. One way worked much better than the other.

Methodology

Patients were randomly assigned to receive either a mucosal advancement flap or fibrin sealant after seton treatment.

Potential Biases

Smoking was identified as a significant risk factor affecting treatment outcomes.

Limitations

The study was stopped early due to unacceptable results in the fibrin sealant group, leading to a small sample size.

Participant Demographics

15 males and 15 females, median ages of 51 years for MF group and 45 years for FS group.

Statistical Information

P-Value

0.03

Statistical Significance

p=0.03

Digital Object Identifier (DOI)

10.1155/2011/186350

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication